2022. EVALUATION OF RISK OF MALIGNANCY INDICES 1, 2, AND 3 IN PRE-OPERATIVE ASSESSMENT OF THE OVARIAN MASSES. Journal of Pharmaceutical Negative Results. (Dec. 2022), 3275–3282.